Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes

NCT03655535 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Type2 Diabetes Mellitus

Interventions

DRUG: BTI320
OTHER: Placebo

Sponsor

Boston Therapeutics

Collaborators

[object Object]